Document is current
Any future updates will be listed below
-
Authors
Martá-Ariza, Mitchell
Leitner, Dominique F.
Kanshin, Evgeny
Suazo, Jianina
Giusti Pedrosa, Ana
Thierry, Manon
Lee, Edward B.
Devinsky, Orrin
Drummond, Eleanor
Fortea, Juan
Lleó, Alberto
Ueberheide, Beatrix
Wisniewski, Thomas
-
Funding
Funding for this research was provided by:
National Institutes of Health (P01AG060882, P30AG072979, P01AG060882)
- License Information
-
More Information
Article History
Received: 8 November 2024
Revised: 2 January 2025
Accepted: 4 January 2025
First Online: 18 January 2025
Declarations
:
: J.F. reported receiving personal fees for service on the advisory boards, adjudication committees or speaker honoraria from AC Immune, Adamed, Alzheon, Biogen, Eisai, Esteve, Fujirebio, Ionis, Laboratorios Carnot, Life Molecular Imaging, Lilly, Lundbeck, Novo Nordisk, Perha, Roche, Zambón and outside the submitted work. J.F. reports holding a patent for markers of synaptopathy in neurodegenerative disease (licensed to ADx, EPI8382175.0).
